These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19630487)

  • 21. Urinary cortisol during exposure in obsessive-compulsive ritualizers.
    Kasvikis YG; Basoglu M; Monteiro W; Marks IM; Lelliott P; Noshirvani H
    Psychiatry Res; 1988 Feb; 23(2):131-5. PubMed ID: 3363021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current issues in the treatment of anxiety states and disorders.
    Psychopharmacol Bull; 1982 Jan; 18(1):36-43. PubMed ID: 7089159
    [No Abstract]   [Full Text] [Related]  

  • 23. Anxiety and OCD - the chicken or the egg?
    Nutt D; Malizia A
    J Psychopharmacol; 2006 Nov; 20(6):729-31. PubMed ID: 17060345
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology.
    Menchon JM; Bobes J; Alamo C; Alonso P; García-Portilla MP; Ibáñez Á; Real E; Bousoño M; Saiz-Gonzalez MD; Saiz-Ruiz J
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(2):77-91. PubMed ID: 30850318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive disorder: The usefulness of a pharmacological practice guideline.
    Menchón JM; Bobes J; Saiz-Ruiz J
    Rev Psiquiatr Salud Ment; 2016; 9(3):131-3. PubMed ID: 27368427
    [No Abstract]   [Full Text] [Related]  

  • 26. What to do about social anxiety disorder. The holidays are coming, with lots of convivial occasions--fun for most, but distressing if you suffer from social phobia.
    Harv Womens Health Watch; 2008 Dec; 16(4):1-3. PubMed ID: 19125452
    [No Abstract]   [Full Text] [Related]  

  • 27. Polypharmacy: when is it rational?
    Preskorn SH; Lacey RL
    J Psychiatr Pract; 2007 Mar; 13(2):97-105. PubMed ID: 17414685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep brain stimulation in obsessive-compulsive disorder.
    Denys D; Mantione M
    Prog Brain Res; 2009; 175():419-27. PubMed ID: 19660670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of vision secondary to obsessive-compulsive disorder: a case report.
    Torres AR; Domingues Mde S; Shiguematsu AI; Smaira SI
    Gen Hosp Psychiatry; 2009; 31(3):292-4. PubMed ID: 19410110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The art of prescribing: pharmacotherapy of obsessive-compulsive disorder: an evidence-based approach.
    Antai-Otong D
    Perspect Psychiatr Care; 2007 Oct; 43(4):219-22. PubMed ID: 17894672
    [No Abstract]   [Full Text] [Related]  

  • 31. Dermatology and conditions related to obsessive-compulsive disorder.
    Koblenzer CS
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):1033-5. PubMed ID: 1479092
    [No Abstract]   [Full Text] [Related]  

  • 32. Trichotillomania: neurobiology and treatment.
    Chamberlain SR; Odlaug BL; Boulougouris V; Fineberg NA; Grant JE
    Neurosci Biobehav Rev; 2009 Jun; 33(6):831-42. PubMed ID: 19428495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral vasculitis and obsessive-compulsive disorder following varicella infection in childhood.
    Yaramiş A; Hergüner S; Kara B; Tatli B; Tüzün U; Ozmen M
    Turk J Pediatr; 2009; 51(1):72-5. PubMed ID: 19378896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Executive functions and the obsessive-compulsive disorder: on the importance of subclinical symptoms and other concomitant factors.
    Bédard MJ; Joyal CC; Godbout L; Chantal S
    Arch Clin Neuropsychol; 2009 Sep; 24(6):585-98. PubMed ID: 19689989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical anorexia in a male patient accompanied by strong obsessive-compulsive symptoms successfully treated with naltrexone.
    Gade K; Häussinger C; Bandelow B
    Pharmacopsychiatry; 2009 Jul; 42(4):164-5. PubMed ID: 19585396
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychopharmacology in dermatology.
    Lee CS; Accordino R; Howard J; Koo J
    Dermatol Ther; 2008; 21(1):69-82. PubMed ID: 18318888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive-behavioral family treatment for childhood obsessive-compulsive disorder: a 7-year follow-up study.
    O'Leary EM; Barrett P; Fjermestad KW
    J Anxiety Disord; 2009 Oct; 23(7):973-8. PubMed ID: 19640677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of intronic variants of the BTBD9 gene with Tourette syndrome.
    Rivière JB; Xiong L; Levchenko A; St-Onge J; Gaspar C; Dion Y; Lespérance P; Tellier G; Richer F; Chouinard S; Rouleau GA;
    Arch Neurol; 2009 Oct; 66(10):1267-72. PubMed ID: 19822783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Narcopsychotherapy of stably fixated neurotic disorders].
    Mishin GI; Varsov VB
    Voen Med Zh; 1975 Sep; (9):41-3. PubMed ID: 1181720
    [No Abstract]   [Full Text] [Related]  

  • 40. Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder.
    Poyurovsky M
    Isr J Psychiatry Relat Sci; 2008; 45(3):219-20. PubMed ID: 19398826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.